KANGO SUJAY

Director at Dianthus Therapeutics, Inc. /DE/ · on record since May 22, 2026
Director at Avantogen Oncology, Inc. · on record since Apr 12, 2006
CEO at Avantogen Oncology, Inc. · on record since Apr 12, 2006
Chief Commercial Officer at INFINITY PHARMACEUTICALS, INC. · on record since Apr 1, 2015
EVP, Chief Commercial Officer at ACCELERON PHARMA INC · on record since Feb 13, 2018
Director at Lite Strategy, Inc. · on record since Nov 23, 2021
Director at INFINITY PHARMACEUTICALS, INC. · on record since Mar 31, 2022

Insider trading activity of KANGO SUJAY

Transactions on record: 49; since Apr 1, 2015

Open-market buys: 0

Open-market sells: 17; $3.7M

Companies traded: 4; last filing May 22, 2026

Figures computed from official regulatory filings — .

Companies where KANGO SUJAY has traded

Dianthus Therapeutics, Inc. /DE/2 tx · May 22, 2026
Lite Strategy, Inc.3 tx · Oct 12, 2023
INFINITY PHARMACEUTICALS, INC.8 tx · $95.9K · Mar 31, 2022
ACCELERON PHARMA INC36 tx · $4.9M · Nov 22, 2021

Track record of KANGO SUJAY

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of KANGO SUJAY

Co-insiders of KANGO SUJAY

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Dianthus Therapeutics, Inc. /DE/Listing on record	May 22, 2026	AwardD (derivative)	6,090	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dianthus Therapeutics, Inc. /DE/Listing on record	Mar 5, 2025	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Oct 12, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Jul 7, 2022	AwardD (derivative)	87,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Mar 31, 2022	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Nov 23, 2021	AwardD (derivative)	58,334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-25,500	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-24,334	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-20,896	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	Other	-18,509	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	Sell	-5,000	175.00 USD	$875K	Unusual size	SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	Sell	-5,000	150.03 USD	$750.2K	Unusual size	SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Jun 8, 2021	Other	-887	130.87 USD	$116.1K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-600	137.12 USD	$82.3K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-2,699	135.48 USD	$365.7K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-200	138.15 USD	$27.6K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-1,501	136.24 USD	$204.5K		SEC
ACCELERON PHARMA INCListing unverified	Feb 2, 2021	Award	5,409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Dianthus Therapeutics, Inc. /DE/Listing on record	May 22, 2026	AwardD (derivative)	6,090	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dianthus Therapeutics, Inc. /DE/Listing on record	Mar 5, 2025	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Oct 12, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Jul 7, 2022	AwardD (derivative)	87,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
INFINITY PHARMACEUTICALS, INC.Listing unverified	Mar 31, 2022	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Lite Strategy, Inc.Listing unverified	Nov 23, 2021	AwardD (derivative)	58,334	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-25,500	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-24,334	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	OtherD (derivative)	-20,896	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Nov 22, 2021	Other	-18,509	—	n/a (No price was disclosed in the filing)		SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	Sell	-5,000	175.00 USD	$875K	Unusual size	SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Sep 27, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	Sell	-5,000	150.03 USD	$750.2K	Unusual size	SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Sep 22, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Jun 8, 2021	Other	-887	130.87 USD	$116.1K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Exercise	5,000	40.61 USD	$203.1K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-600	137.12 USD	$82.3K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-2,699	135.48 USD	$365.7K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-200	138.15 USD	$27.6K		SEC
ACCELERON PHARMA INCListing unverified	Mar 4, 2021	Sell	-1,501	136.24 USD	$204.5K		SEC
ACCELERON PHARMA INCListing unverified	Feb 2, 2021	Award	5,409	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC